Montana Legislature updates medical marijuana regulations on THC potency limits

Senate Bill 255, introduced in the Montana Legislature on February 4, 2025, aims to amend existing regulations surrounding the sale and distribution of medical marijuana products in the state. The bill primarily focuses on establishing specific limits for tetrahydrocannabinol (THC) content in various marijuana products, including edibles, suppositories, and transdermal patches.

Key provisions of the bill stipulate that marijuana products sold as edibles or other forms cannot exceed 800 milligrams of THC per package, while suppositories and transdermal patches are limited to 100 milligrams of THC each, with the same package limit of 800 milligrams. Additionally, the bill allows for a 10% deviation from these limits, providing some flexibility for dispensaries. Notably, registered cardholders may purchase products with higher THC levels than those specified in the bill, reflecting an effort to accommodate patients with specific medical needs.

The bill has sparked discussions among lawmakers and stakeholders regarding its implications for patient access and safety. Proponents argue that the regulations are necessary to ensure responsible use and prevent overconsumption, while opponents express concerns that the limits may hinder access for patients who require higher doses for effective treatment.

The economic implications of Senate Bill 255 could be significant, as it may affect the operations of dispensaries and the overall medical marijuana market in Montana. By establishing clear guidelines, the bill seeks to create a more regulated environment, which could enhance consumer confidence but may also lead to increased operational costs for businesses.

As the legislative process continues, experts suggest that the outcome of this bill could set a precedent for future marijuana legislation in Montana, particularly as the state navigates the evolving landscape of cannabis regulation. The next steps will involve further debates and potential amendments as lawmakers consider the balance between patient access and public safety.